MeCure targets N50bn capital boost for West African expansion
Nigerian pharmaceutical powerhouse MeCure Industries is set to raise its capital target to N50 billion, cementing its ambitious expansion plans across Nigeria and West Africa. This strategic move follows a stellar financial year, marked by a 177% profit surge and significant revenue growth, underscoring the company's robust market position and future potential within the region's healthcare sector.
MeCure Industries Plc has proposed increasing its capital-raising programme to N50 billion from N30 billion as the pharmaceutical manufacturer accelerates its expansion across Nigeria and West Africa. The proposal followed the company’s impressive 2025 financial performance
This story was sourced from Tribune Online and rewritten in SEVA editorial voice. Read the full original at the source.